Community-associated Methicillin-resistant Staphylococcus aureus in Acute Musculoskeletal Infection in Children: A Game Changer

Journal of Pediatric Orthopaedics

Volumn 29, Issue 8, 2009, Pages 927-931

  Vander Have, Kelly L ^a   Karmazyn, Boaz ^b   Verma, Maneesh ^a   Caird, Michelle S ^a   Hensinger, Robert N ^a   Farley, Frances A ^a   Lubicky, John P ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

Community acquired; Infection; MRSA

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; LINEZOLID; MEDRONATE TECHNETIUM TC 99M; METICILLIN; VANCOMYCIN; WARFARIN;

ACUTE DISEASE; ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BLOOD CULTURE; BONE SCINTISCANNING; CHILD; CLINICAL ARTICLE; COMMUNITY ACQUIRED INFECTION; DEBRIDEMENT; DEEP VEIN THROMBOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INFANT; LUNG EMBOLISM; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDETECTOR COMPUTED TOMOGRAPHY; MUSCULOSKELETAL DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VENA CAVA FILTER;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ARTHRITIS, INFECTIOUS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MUSCULOSKELETAL DISEASES; OSTEOMYELITIS; PYOMYOSITIS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 74249105921     PISSN: 02716798     EISSN: None     Source Type: Journal    
DOI: 10.1097/BPO.0b013e3181bd1e0c     Document Type: Article

References (24)

1. Chambers HF. The changing epidemiology of Staphyloccus aureus? Emerg Infect Dis. 2001;7:178-182.
2. Eady EA, Cove JH. Staphyloccal resistance revisited: communityacquired methicillin resistant Staphyloccus aureus-an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis. 2003;16:103-124.
3. Arnold SR, Elias D, Buckingham SC, et al. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community associated methicillin resistant Staphylococcus aureus. J Pediatr Orthop. 2006;26:703-708.
4. LeClercq R. Epidemiological and resistance issues in multidrug resistant staphylococci and enterococci. Clin Microbiol Infect. 2009; 15:224-231.
5. Cohen PR. Community acquired methicillin resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management and prevention. Int J Dermatol. 2007;46:1-11.
6. Pannaraj PS, Hulten KG, Gonzalez BE, et al. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin- resistant Staphylococcus aureus infection. Clin Infect Dis. 2006; 43:953-960.
7. Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, et al. Communityacquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J. 2004;23:701-706.
8. Panton PN, Valentine FCO. Staphylococcal toxin. Lancet. 1932;219: 506-508.
9. Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002;359:1819-1827.
10. Diep BA, Carleton HA, Chang RF, et al. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin- resistant Staphyloccus aureus. J Infect Dis. 2006;193: 1495-1503.
11. Bocchini CE, Hulten KG, Mason EO, et al. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphyloccus aureus osteomyelitis in children. Pediatrics. 2006;117:433-440.
12. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine Leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9:978-984.
13. Goergens ED, McEvoy A, Watson M, et al. Acute osteomyelitis and septic arthritis in children. J Paediatr Child Health. 2005;41: 59-62.
14. Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe Staphylococcal sepsis in adolescents in the era of communityacquired methicillin-resistant Staphylococcus aureus. Pediatrics. 2005; 115:642-648.
15. Voss L, Segedin E, Anderson BJ. Review of Staphylococcus aureus infections requiring admission to a paediatric intensive care unit. Arch Dis Child. 2005;90:1274-1278.
16. Sattler CA, Mason EO, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community acquired methicillin resistant versus methicillin susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002;21: 910-917.
17. Moumile K, Cadilhac C, Lina G, et al. Severe osteoarticular infection associated with Panton-Valentine leukocidin-producing Staphylococcus aureus. Diagn Microbiol Infect Dis. 2006;56: 95-97.
18. Shulman ST, Ayoub EM. Severe staphylococcal sepsis in adolescents. Pediatrics. 1976;58:59-66.
19. Walsh S, Phillips F. Deep vein thrombosis associated with pediatric musculoskeletal sepsis. J Pediatr Orthop. 2002;22:329-332.
20. Gonzalez BE, Teruya J, Mahoney DH, et al. Venous thrombosis associated with Staphylococcal osteomyelitis in children. Pediatrics. 2006;117:1673-1679.
21. Gorenstein A, Gross E, Houri S, et al. The pivotal role of deep vein thrombosis in the development of acute disseminated Staphylococcal disease in children. Pediatrics. 2000;106:87-90.
22. Browne LP, Mason EO, Kaplan SL, et al. Optimal imaging strategy for community acquired Staphylococcus aureus musculoskeletal infections in children. Pediatr Radiol. 2008;38: 841-847.
23. Lewis JS II, Jorgensen JH. Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis. 2005;40:280-285.
24. Chavez-Bueno S, Bozdogan B, Katz K, et al. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community acquired methicillin resistant Staphylococcus aureus in Dallas. Antimicrob Agents Chemother. 2005;49: 2283-2288.